<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82690</article-id><article-id pub-id-type="doi">10.7554/eLife.82690</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Evidence for virus-mediated oncogenesis in bladder cancers arising in solid organ transplant recipients</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-157914"><name><surname>Starrett</surname><given-names>Gabriel J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5871-5306</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293460"><name><surname>Yu</surname><given-names>Kelly</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293461"><name><surname>Golubeva</surname><given-names>Yelena</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-293462"><name><surname>Lenz</surname><given-names>Petra</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-293463"><name><surname>Piaskowski</surname><given-names>Mary L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8453-6416</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293464"><name><surname>Petersen</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29104"><name><surname>Dean</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293465"><name><surname>Israni</surname><given-names>Ajay</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293466"><name><surname>Hernandez</surname><given-names>Brenda Y</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293467"><name><surname>Tucker</surname><given-names>Thomas C</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261588"><name><surname>Cheng</surname><given-names>Iona</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293468"><name><surname>Gonsalves</surname><given-names>Lou</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293469"><name><surname>Morris</surname><given-names>Cyllene R</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293470"><name><surname>Hussain</surname><given-names>Shehnaz K</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293471"><name><surname>Lynch</surname><given-names>Charles F</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276923"><name><surname>Harris</surname><given-names>Reuben S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9034-9112</contrib-id><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-125431"><name><surname>Prokunina-Olsson</surname><given-names>Ludmila</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9622-2091</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-165483"><name><surname>Meltzer</surname><given-names>Paul S</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31561"><name><surname>Buck</surname><given-names>Christopher B</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3165-8094</contrib-id><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293472"><name><surname>Engels</surname><given-names>Eric A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Laboratory of Cellular Oncology</institution>, <institution>National Cancer Institute</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>National Cancer Institute</institution>, <addr-line><named-content content-type="city">Rockville</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Leidos Biomedical Research Inc</institution>, <addr-line><named-content content-type="city">Frederick</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Medicine</institution>, <institution>University of Minnesota</institution>, <addr-line><named-content content-type="city">Minneapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Cancer Center</institution>, <institution>University of Hawaii</institution>, <addr-line><named-content content-type="city">Honolulu</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">The Kentucky Cancer Registry</institution>, <institution>University of Kentucky</institution>, <addr-line><named-content content-type="city">Lexington</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Epidemiology and Biostatistics</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">Fremont</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Connecticut Tumor Registry</institution>, <institution>Connecticut Department of Public Health</institution>, <addr-line><named-content content-type="city">Hartford</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">California Cancer Reporting and Epidemiologic Surveillance Program</institution>, <institution>University of California, Davis</institution>, <addr-line><named-content content-type="city">Davis</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Department of Medicine</institution>, <institution>Cedars-Sinai Medical Center</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff11"><institution content-type="dept">The Iowa Cancer Registry</institution>, <institution>University of Iowa</institution>, <addr-line><named-content content-type="city">Iowa City</named-content></addr-line>, <country>United States</country></aff><aff id="aff12"><institution>Howard Hughes Medical Institute, University of Minnesota-Twin Cities</institution>, <addr-line><named-content content-type="city">Minneapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff13"><institution content-type="dept">Molecular Genetics Section</institution>, <institution>National Cancer Institute</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><aff id="aff14"><institution content-type="dept">Lab of Cellular Oncology</institution>, <institution>National Cancer Institute</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-286356"><name><surname>Wallace</surname><given-names>Nicholas</given-names></name><role>Reviewing editor</role><aff><institution>Kansas State University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>gabe.starrett@nih.gov</email> (GS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e82690</elocation-id><history><date date-type="received"><day>13</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>22</day><month>03</month><year>2023</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82690-v1.pdf"/><abstract><p>A small percentage of bladder cancers in the general population have been found to harbor DNA viruses. In contrast, up to 25% of tumors of solid organ transplant recipients, who are at an increased risk of developing bladder cancer and have overall poorer outcome, harbor BK polyomavirus (BKPyV). To better understand the biology of the tumors and the mechanisms of carcinogenesis from potential oncoviruses, we performed whole genome and transcriptome sequencing on bladder cancer specimens from 43 transplant patients. Nearly half of tumors from this patient population contained viral sequences. The most common were from BKPyV (N=9, 21%), JC polyomavirus (N=7, 16%), carcinogenic human papillomaviruses (N=3, 7%), and torque teno viruses (N=5, 12%). Immunohistochemistry revealed variable Large T antigen expression in BKPyV-positive tumors ranging from 100% positive staining of tumor tissue to less than 1%. In most cases of BKPyV-positive tumors, the viral genome appeared to be clonally integrated into the host chromosome consistent with microhomology-mediated end joining and coincided with focal amplifications of the tumor genome similar to other virus-mediated cancers. Significant changes in host gene expression consistent with the functions of BKPyV Large T antigen were also observed in these tumors. Lastly, we identified four mutation signatures in our cases with those attributable to APOBEC3 and SBS5 being the most abundant. Mutation signatures associated with the antiviral drug, ganciclovir, and aristolochic acid, a nephrotoxic compound found in some herbal medicines, were also observed. The results suggest multiple pathways to carcinogenesis in solid organ transplant recipients with a large fraction being virus-associated.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>Intramural Research Program</award-id><principal-award-recipient><name><surname>Starrett</surname><given-names>Gabriel J</given-names></name><name><surname>Buck</surname><given-names>Christopher B</given-names></name><name><surname>Engels</surname><given-names>Eric A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Yelena Golubeva, is affiliated with Leidos Biomedical Research Inc. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf3"><p>Petra Lenz, is affiliated with Leidos Biomedical Research Inc. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf4"><p>Reuben S Harris, is a co-founder, shareholder, and consultant of ApoGen Biotechnologies Inc. The remaining authors have no competing interests to declare..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The TCM Study is considered non-human subjects research at the National Institutes of Health because researchers do not receive identifying information on patients, and the present project utilizes materials collected previously for clinical purposes. The TCM Study was reviewed, as required, by human subjects committees at participating cancer registries.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All refseqs for human papillomaviruses were downloaded from PaVE and refseqs for human polyomaviruses were downloaded from NCBI as of November 2018. All sequencing data generated in this study are available from dbGaP under accession phs003012.v1.p1. Viral contigs from this study are deposited in GenBank under accessions OQ469311 and OQ469312. All other contigs and larger IHC images are deposited in figshare (https://figshare.com/projects/Common_Mechanisms_of_Virus-Mediated_Oncogenesis_in_Bladder_Cancers_Arising_in_Solid_Organ_Transplant_Recipients/132833). Code used in this manuscript are available from www.github.com/gstarrett/oncovirus_tools.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Starrett GJ</collab></person-group><year iso-8601-date="2022">2022</year><source>Multi-omics of Bladder Cancers of Solid Organ Transplant Recipients</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gap/">https://www.ncbi.nlm.nih.gov/gap/</ext-link><comment>dbGaP phs003012.v1.p1</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-82690-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>